A recent report by van Diepen and colleagues, as featured in the latest edition of the Journal, presents the efficacy and safety aspects of Proton Pump Inhibitors (PPIs) compared to Histamine-2 Receptor Blockers (H2RBs). These drugs are used for stress ulcer prophylaxis in patients in cardiac surgery intensive care units. The study is of particular…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest